S 17092: A Prolyl Endopeptidase Inhibitor as a Potential Therapeutic Drug for Memory Impairment. Preclinical and Clinical Studies
| Autor: | Pierre-Alain Boyer, Philippe Morain, Jean-Loïc Robin, Pierre Lestage, Guillaume De Nanteuil, David Guez, Roeline Jochemsen |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Aging
Indoles Serine Proteinase Inhibitors Amnesia Substance P Pharmacology Neuroprotection Article chemistry.chemical_compound Prolyl endopeptidase medicine Animals Humans Learning Memory impairment Memory Disorders Working memory Serine Endopeptidases Cognition S-17092 Thiazoles Neuropsychology and Physiological Psychology chemistry Mechanism of action Models Animal Thiazolidines medicine.symptom Cognition Disorders Prolyl Oligopeptidases Psychology Neuroscience medicine.drug |
| Zdroj: | CNS Drug Reviews. 8:31-52 |
| ISSN: | 1080-563X |
| DOI: | 10.1111/j.1527-3458.2002.tb00214.x |
| Popis: | Any treatment that could positively modulate central neuropeptides levels would provide a promising therapeutic approach to the treatment of cognitive deficits associated with aging and/or neurodegenerative diseases. Therefore, based on the activity in rodents, S 17092 (2S,3aS,7aS)‐1 ([(R.R)‐2‐phenylcyclopropyl]carbonyl)‐2‐[(thiazolidin‐3‐yl)car‐bonyl]octahydro‐1H‐indole) has been selected as a potent inhibitor of cerebral prolyl‐endopeptidase (PEP). By retarding the degradation of neuroactive peptides, S 17092 was successfully used in a variety of memory tasks. These tasks explored short‐term, long‐term, reference and working memory in aged mice, as well as in rodents and monkeys with chemically induced amnesia or spontaneous memory deficits. S 17092 has also been safely administered to humans, and showed a clear peripheral expression of its mechanism of action through its inhibitory effect upon PEP activity in plasma. S 17092 exhibited central effects, as evidenced by EEG recording in healthy volunteers, and could improve a delayed verbal memory task. Collectively, the preclinical and clinical effects of S 17092 have suggested a promising role for this compound as an agent for the treatment of cognitive disorders associated with cerebral aging. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text